These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 10811396)
21. Update on fetal transplantation: the Swedish experience. Lindvall O Mov Disord; 1998; 13 Suppl 1():83-7. PubMed ID: 9613723 [TBL] [Abstract][Full Text] [Related]
22. Cerebral transplantation for Parkinson's disease: current progress and future prospects. Ahlskog JE Mayo Clin Proc; 1993 Jun; 68(6):578-91. PubMed ID: 8497136 [TBL] [Abstract][Full Text] [Related]
23. Fetal porcine ventral mesencephalon graft. Determination of the optimal gestational age for implantation in parkinsonian patients. HogenEsch RI; Koopmans J; Copray JC; van Roon WM; Kema I; Molenaar G; Go KG; Staal MJ Exp Brain Res; 2000 Jun; 132(3):345-50. PubMed ID: 10883382 [TBL] [Abstract][Full Text] [Related]
24. [Experimental clinical transplantation in patients with Parkinson disease. Experimental background and clinical picture]. Ostergaard K; Rasmussen JZ Ugeskr Laeger; 1991 Dec; 153(50):3554-8. PubMed ID: 1776197 [TBL] [Abstract][Full Text] [Related]
25. Neural transplantation in Parkinson's disease. Lindvall O Novartis Found Symp; 2000; 231():110-23; discussion 123-8, 145-7. PubMed ID: 11131534 [TBL] [Abstract][Full Text] [Related]
26. Why do neural transplants survive? An examination of some metabolic and pathophysiological considerations in neural transplantation. Rosenstein JM Exp Neurol; 1995 May; 133(1):1-6. PubMed ID: 7601258 [TBL] [Abstract][Full Text] [Related]
27. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology. Galpern WR; Burns LH; Deacon TW; Dinsmore J; Isacson O Exp Neurol; 1996 Jul; 140(1):1-13. PubMed ID: 8682173 [TBL] [Abstract][Full Text] [Related]
28. Ethical challenges in cell-based interventions for neurological conditions: some lessons to be learnt from clinical transplantation trials in patients with Parkinson's disease. Hildt E Am J Bioeth; 2009 May; 9(5):37-8. PubMed ID: 19396682 [No Abstract] [Full Text] [Related]
29. Neural transplantation in Parkinson's disease. Mehta V; Spears J; Mendez I Can J Neurol Sci; 1997 Nov; 24(4):292-301. PubMed ID: 9398975 [TBL] [Abstract][Full Text] [Related]
30. Adrenal medulla in neural grafting and neural plasticity. Hansen JT; Gash DM Microsc Res Tech; 1994 Oct; 29(2):155-60. PubMed ID: 7812037 [TBL] [Abstract][Full Text] [Related]
31. [Outlook for the use of nerve tissue xenotransplantation in neurosurgery]. Savel'ev SV Arkh Patol; 1995; 57(2):11-8. PubMed ID: 7611889 [TBL] [Abstract][Full Text] [Related]
32. Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection. Larsson LC; Frielingsdorf H; Mirza B; Hansson SJ; Anderson P; Czech KA; Strandberg M; Widner H Exp Neurol; 2001 Nov; 172(1):100-14. PubMed ID: 11681844 [TBL] [Abstract][Full Text] [Related]
33. [Use of neurotransplantation in the treatment of Parkinson's disease]. Ugriumov MV; Shabalov VA; Fedorova NV; Popov AP; Shtok VN; Sotnikova EI; Melikian AG; Gatina TA; Fetisov SO; Arkhipova NA; Buklina SB; Lutsenko GV Vestn Ross Akad Med Nauk; 1996; (8):40-51. PubMed ID: 8963196 [TBL] [Abstract][Full Text] [Related]
34. Transplants in Parkinson's disease. Lindvall O Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521 [TBL] [Abstract][Full Text] [Related]
35. Neural xenotransplantation: pretreatment of porcine embryonic nigral tissue with anti-Gal antibodies and complement is not toxic for the dopaminergic neurons. Brevig T; Meyer M; Kristensen T; Zimmer J Cell Transplant; 2001; 10(1):25-30. PubMed ID: 11294468 [TBL] [Abstract][Full Text] [Related]
36. Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease. Büchele F; Döbrössy M; Hackl C; Jiang W; Papazoglou A; Nikkhah G Neurobiol Dis; 2014 Aug; 68():112-25. PubMed ID: 24780496 [TBL] [Abstract][Full Text] [Related]
37. Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease. Harrower TP; Tyers P; Hooks Y; Barker RA Exp Neurol; 2006 Jan; 197(1):56-69. PubMed ID: 16246328 [TBL] [Abstract][Full Text] [Related]
38. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses. Denner J; Schuurman HJ; Patience C Xenotransplantation; 2009; 16(4):239-48. PubMed ID: 19799764 [TBL] [Abstract][Full Text] [Related]
39. Neural xenotransplantation: reconstruction of neuronal circuitry across species barriers. Pakzaban P; Isacson O Neuroscience; 1994 Oct; 62(4):989-1001. PubMed ID: 7845600 [TBL] [Abstract][Full Text] [Related]
40. Innovative treatment or ethical headache? Fetal transplantation in Parkinson's disease. Fletcher S Prof Nurse; 1992 Jun; 7(9):592-5. PubMed ID: 1598349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]